EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comprehensive evaluation of immunological attributes and immunotherapy responses of positive T cell function regulators in colorectal cancer

Ke Pu, Jingyuan Gao, Yang Feng, Jian Hu, Shunli Tang, Guodong Yang, Chuan Xu

BMC Gastroenterology · 2024

DOI: 10.1186/s12876-024-03409-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BMC Gastroenterology, 2024. Verfasst von Ke Pu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Tumor Microenvironment, Immunotherapy, Microsatellite Instability. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Intramural Fund of North Sichuan Medical College, Nanchong City Talent Development Fund, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Positive regulators of T-cell function (PTFRs), integral to T-cell proliferation and activation, have been identified as potential prognostic markers in colorectal cancer (CRC). Despite this, their role within the tumor microenvironment (TME) and their response to immunotherapy are not yet fully understood. METHODS: This study delved into PTFR-related CRC subtypes by analyzing four independent transcriptome datasets, emphasizing the most significant prognostic PTFRs. We identified differentially expressed genes (DEGs) between two subtypes and developed a PTFR risk model using LASSO and Cox regression methods. The model's associations with survival time, clinical features, TME characteristics, tumor mutation profiles, microsatellite instability (MSI), cancer stem cell (CSC) index, and responses to chemotherapy, targeted therapy, and immunotherapy were subsequently explored. RESULTS: The PTFR risk model demonstrated a strong predictive capacity for CRC. It facilitated the estimation of immune cell composition, HLA expression levels, immune checkpoint expression, mutation burden, CSC index features, and the effectiveness of immunotherapy. CONCLUSIONS: This study enhances our understanding of the role of PTFRs in CRC progression and introduces an innovative assessment framework for CRC immunotherapy. This framework improves the prediction of treatment outcomes and aids in the customization of therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsTumor MicroenvironmentImmunotherapyMicrosatellite InstabilityHumansPrognosisT-LymphocytesTranscriptomeBiomarkers, TumorNeoplastic Stem CellsFemaleMutation

Stichwörter der Autor:innen

Colorectal CancerImmunotherapyRisk score modelT-cell function positive regulatorsTumor microenvironment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Gastroenterology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, China.
  • Department of Immunology, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China.
  • Department of Neurosurgery, Xi'an No.3 Hospital, the Affiliated Hospital of Northwest University, Xi'an, Shaanxi, 710018, China.
  • Department of Thoracic and Cardiovascular Surgery, Dazhou Second People's Hospital, Integrated TCM & Western Medicine Hospital, Dazhou, 635000, China.
  • Department of Pathology, Dazhou Second People's Hospital, Integrated TCM & Western Medicine Hospital, Dazhou, 635000, China.
  • Department of Gastroenterology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, 637000, China. ygd_ld2006@163.com.

Förderung

  • The Intramural Fund of North Sichuan Medical College
  • Nanchong City Talent Development Fund
  • National Natural Science Foundation of China
  • Medico-Engineering Cooperation Funds from University of Electronic Science and Technology of China

Zitieren

APA

Pu, K., Gao, J., Feng, Y., Hu, J., Tang, S., Yang, G., & Xu, C. (2024). Comprehensive evaluation of immunological attributes and immunotherapy responses of positive T cell function regulators in colorectal cancer. BMC Gastroenterology. https://doi.org/10.1186/s12876-024-03409-2

Vancouver

Pu K, Gao J, Feng Y, Hu J, Tang S, Yang G, et al. Comprehensive evaluation of immunological attributes and immunotherapy responses of positive T cell function regulators in colorectal cancer. BMC Gastroenterology. 2024. doi:10.1186/s12876-024-03409-2

BibTeX
@article{Pu2024,
  author = {Pu, Ke and Gao, Jingyuan and Feng, Yang and Hu, Jian and Tang, Shunli and Yang, Guodong and Xu, Chuan},
  title = {Comprehensive evaluation of immunological attributes and immunotherapy responses of positive T cell function regulators in colorectal cancer},
  journal = {BMC Gastroenterology},
  year = {2024},
  doi = {10.1186/s12876-024-03409-2}
}
Kostenlos starten →